Banque Cantonale Vaudoise Bio N Tech Se Transaction History

Banque Cantonale Vaudoise

$2.55 Billion
Q1 2024

A detailed history of Banque Cantonale Vaudoise transactions in Bio N Tech Se stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 2,474 shares of BNTX stock, worth $194,852. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,474

Previous 2,534 2.37%

Holding current value

$194,852

Previous $266,000 13.91%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$88.96 - $112.35 $5,337 - $6,741	-60 Reduced 2.37%	2,474 $229,000
Q3 2023 Nov 08, 2023	SELL	$98.5 - $125.08 $3,053 - $3,877	-31 Reduced 1.21%	2,534 $273,000
Q2 2023 Aug 09, 2023	SELL	$102.58 - $129.66 $23,490 - $29,692	-229 Reduced 8.2%	2,565 $277,000
Q1 2023 Apr 20, 2023	BUY	$122.57 - $153.67 $83,470 - $104,649	681 Added 32.23%	2,794 $347,000
Q4 2022 Feb 10, 2023	SELL	$118.43 - $186.05 $1.43 Million - $2.25 Million	-12,100 Reduced 85.13%	2,113 $320,000

Q3 2022 Oct 17, 2022	BUY	$127.65 - $183.11 $77,355 - $110,964	606 Added 4.45%	14,213 $1.92 Million
Q2 2022 Aug 02, 2022	BUY	$123.25 - $186.24 $850,671 - $1.29 Million	6,902 Added 102.94%	13,607 $2.03 Million
Q1 2022 May 09, 2022	SELL	$126.25 - $231.85 $699,046 - $1.28 Million	-5,537 Reduced 45.23%	6,705 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $337,308 - $564,443	1,557 Added 14.57%	12,242 $3.15 Million
Q3 2021 Oct 29, 2021	SELL	$205.93 - $447.23 $75,164 - $163,238	-365 Reduced 3.3%	10,685 $2.92 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $1.13 Million - $2.41 Million	10,000 Added 952.38%	11,050 $2.47 Million
Q1 2021 May 11, 2021	BUY	$85.73 - $119.5 $90,016 - $125,475	1,050 New	1,050 $114,000
Q3 2020 Oct 30, 2020	SELL	$57.81 - $104.17 $21,389 - $38,542	-370 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$38.58 - $66.74 $14,274 - $24,693	370 New	370 $25,000

Others Institutions Holding BNTX

# of Institutions

326

Shares Held

40.4M

Call Options Held

1.31M

Put Options Held

1.37M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Bio N Tech Se Transaction History